Default: Clinical Pharmacology and Therapeutics

ISSN: 0009-9236

Journal Home

Journal Guideline

Clinical Pharmacology and Therapeutics Q1 Unclaimed

Wiley-Blackwell United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Pharmacology and Therapeutics is a journal indexed in SJR in Pharmacology and Pharmacology (medical) with an H index of 183. It has an SJR impact factor of 1,986 and it has a best quartile of Q1. It is published in English.

Clinical Pharmacology and Therapeutics focuses its scope in these topics and keywords: acid, cysteine, drug, clinical, medicines, variability, role, study, trials, allelic, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

- €

Gold OA

-

Green OA

- €

Non OA

Metrics

Clinical Pharmacology and Therapeutics

1,986

SJR Impact factor

183

H Index

418

Total Docs (Last Year)

729

Total Docs (3 years)

12774

Total Refs

3301

Total Cites (3 years)

556

Citable Docs (3 years)

6,39

Cites/Doc (2 years)

30,56

Ref/Doc

Aims and Scope


acid, cysteine, drug, clinical, medicines, variability, role, study, trials, allelic, randomized, evidence, genotype, parkinsons, proteome, rate, approach, childrenlowdose, amino, anagrelide, analgesia, antibodiesassessment, antidote, application,


Best articles

"Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials?

View more

A better estimate of lognormal means on pharmacokinetic data

View more

A message from the ASCPT Membership Committee Chairperson

View more

A novel chicken embryo model for the investigation of drugs with antimetastatic properties

View more

A novel PD model for gatifloxacin (GF) vs. salmonella typhi (ST) in timed kill curves (KC)

View more

A population pharmacokinetic (PK) and pharmacodynamic (PD) analysis of cinacalcet HCL in renal-dialysis patients with secondary hyperparathyroidism (HPT)

View more

Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval

View more

Ammonia-Lowering Strategies for the Treatment of Hepatic Encephalopathy

View more

An evaluation of optimal sampling strategy and adaptive study design

View more

Apoptosis in anti-tumor effect of irinotecan is mediated by p53 in human hepatocellular carcinoma cell line

View more

Application of a map Bayesian method for CYP2E1 phenotyping

View more

Beta1-adrenergic receptor polymorphisms and hypertension

View more
SHOW MORE ARTICLES

Comparison of genotypic and phenotypic strategies for individualized therapy with the narrow therapeutic drug warfarin

View more

COX-2 inhibitors and carbonic anhydrase activity

View more

CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone

View more

Cytochrome P450 eicosanoids regulate fatty acid metabolism via PPARa

View more

Defining the inhibitory potential of uremic toxins on erythromycin hepatic metabolism

View more

Delayed disposition of cocaine in sweat patches and in skin blister: cocaine may migrate from plasma to sweat patches via interstitial fluid

View more

Disposition of Acetaminophen at 4, 6, and 8g/day for 3 Days in Healthy Young Adults

View more

Effect of diet on caffeine elimination in healthy infants

View more

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

View more

Effect of injection site on relative bioavailability of exenatide (synthetic exendin-4)

View more

Effect of steroids on cerebrospinal fluid penetration of antituberculous drugs in tuberculous meningitis

View more

Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients

View more

Comments

No comments ... Be the first to comment!